Company Zylox-Tonbridge Medical Technology Co., Ltd.
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.68 HKD | +1.71% | +3.29% | -14.15% |
22/03 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
21/03 | Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 765
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Neurovascular Interventional Devices
72.3
%
| 271 | 69.9 % | 422 | 72.3 % | +55.44% |
Peripheral-vascular Interventional Devices
27.4
%
| 117 | 30.1 % | 160 | 27.4 % | +36.51% |
Others
0.2
%
| - | - | 1 | 0.2 % | - |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
97.3
%
| 379 | 97.7 % | 567 | 97.3 % | +49.54% |
Others
2.7
%
| 9 | 2.3 % | 16 | 2.7 % | +73.96% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhong Zhao
CEO | Chief Executive Officer | 58 | 06/12/06 |
Quan Wei Yuan
DFI | Director of Finance/CFO | 46 | 01/21/01 |
Ning Pan
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/19/01 |
Zheng Li
BRD | Director/Board Member | 47 | 31/19/31 |
Yang Xie
BRD | Director/Board Member | 55 | 01/18/01 |
Sau In Kwan
SEC | Corporate Secretary | - | 05/22/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Ze Liang
BRD | Director/Board Member | 53 | 02/21/02 |
Hui Wang
BRD | Director/Board Member | 52 | 01/15/01 |
Da Song Wang
BRD | Director/Board Member | 56 | 13/20/13 |
Zhong Zhao
CEO | Chief Executive Officer | 58 | 06/12/06 |
Yang Xie
BRD | Director/Board Member | 55 | 01/18/01 |
Zheng Li
BRD | Director/Board Member | 47 | 31/19/31 |
Jian Ji
BRD | Director/Board Member | 54 | 02/21/02 |
Hong Bo Wang
BRD | Director/Board Member | 35 | 01/21/01 |
Dong Fang Li
BRD | Director/Board Member | 36 | 18/22/18 |
Changan Ma
BRD | Director/Board Member | - | 17/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 7,781,257 | 0 | 0 | 32.19 % |
Stock B | 1 | 324,619,744 | 0 | 0 | |
Stock C | 1 | 324,619,744 | 211,494,648 ( 65.15 %) | 0 |
Company contact information
Zylox-Tonbridge Medical Technology Co., Ltd.
270 Shuyun Road Cangqian Street
311121, Hangzhou
+86 571 8861 0082
http://www.zyloxtb.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.15% | 440M | |
-7.35% | 10.74B | |
+2.17% | 8.93B | |
+24.70% | 7.61B | |
+32.39% | 5.27B | |
+7.86% | 3.42B | |
-7.14% | 2.86B | |
-5.07% | 2.23B | |
-4.22% | 2.13B | |
-20.87% | 1.84B |
- Stock Market
- Equities
- 2190 Stock
- Company Zylox-Tonbridge Medical Technology Co., Ltd.